COMMUNIQUÉS West-GlobeNewswire

Philips teams up with PURE on pioneering tele-ultrasound program linking specialists around the globe with physicians in Rwanda
19/09/2019
September 19, 2019 Unique intercontinental tele-ultrasound program allows physicians based in Europe and the U.S. to support emergency medicine physician training over 10,000 km (6000 miles) away in Rwanda, boosting the [...]
Eidos Therapeutics to Present at the 2019 Cantor Global Healthcare Conference
19/09/2019
SAN FRANCISCO, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Eidos Therapeutics, Inc. (Eidos) (Nasdaq: EIDX ) today announced that management will present at the 2019 Cantor Global Healthcare Conference on Thursday, October 3 rd [...]
Momenta Pharmaceuticals Appoints Dr. Donna Grogan to Board of Directors
19/09/2019
CAMBRIDGE, Mass., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc . (Nasdaq: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated [...]
PDS Biotechnology Reports Clinical Data for Its Novel Immunotherapy PDS0101 in Follow up to Phase 1 Human Trial
19/09/2019
60% of evaluable patients demonstrated a clinical response Clinical activity observed at all dose levels Data support previously reported in-vivo induction of active HPV-specific (granzyme B-inducing) CD8 + (killer) T- [...]
Soleno Therapeutics to Participate in the Oppenheimer Fall Summit Focused on Specialty Pharma & Rare Disease Companies
19/09/2019
REDWOOD CITY, Calif., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, [...]
Neoleukin Therapeutics Announces Additions to Management Team
19/09/2019
Leslie Aberman, Vice President, Legal Affairs and Intellectual Property Samantha Willing, Vice President, People SEATTLE, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc. (“Neoleukin”) (NASDAQ:NLTX), a [...]
Foamix Announces Enrollment of First Patient in Phase 2 Acne Clinical Trial for FCD105 Minocycline 3% and Adapalene 0.3% Combination Foam
19/09/2019
REHOVOT, Israel and BRIDGEWATER, N.J., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), today announced that the first patient has been enrolled in its Phase 2 clinical trial to evaluate the [...]
MediPharm Labs and Cronos Group Enter Private Label Contract Manufacturing Agreement
19/09/2019
MediPharm to produce high-quality cannabis concentrate filled vapes for Cronos Group Deal reinforces MediPharm Labs’ leadership in large scale manufacturing and distribution TORONTO, Sept. 19, 2019 (GLOBE NEWSWIRE) -- [...]
Strongbridge Biopharma plc Announces RECORLEV™ (levoketoconazole) Phase 3 SONICS Data Published in The Lancet Diabetes & Endocrinology
19/09/2019
~ RECORLEV Resulted in Sustained Improvements in Urinary Free Cortisol (UFC) and Provided Clinical Benefit, As Demonstrated By Improvements in Comorbidities and Characteristic Signs and Symptoms of Cushing’s Syndrome [...]
T2 Biosystems Reports Granting of Inducement Awards
19/09/2019
LEXINGTON, Mass., Sept. 19, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare [...]
Theratechnologies Reaches Agreement With AIDS Drug Assistance Program (ADAP) for New EGRIFTA SV™
19/09/2019
Agreement for Trogarzo® renewed MONTREAL, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH) is pleased to announce that an agreement has been reached with the AIDS Drug Assistance Program Crisis Task [...]
Theratechnologies conclut une entente avec le AIDS Drug Assistance Program (ADAP) pour le nouveau EGRIFTA SV(MC)
19/09/2019
L’entente pour Trogarzo(MD) est renouvelée MONTRÉAL, 19 sept. 2019 (GLOBE NEWSWIRE) -- Theratechnologies inc. (TSX: TH) est heureuse d’annoncer qu’une entente a été conclue avec le groupe de travail du AIDS Drug [...]
CB2 Insights Licenses Electronic Data Capture Software to MyAccess Clinics for Use In the UK
19/09/2019
Company strengthens market presence in United Kingdom with licensing of Electronic Data Capture Technology in partnership with UK-based MyAccess Clinics MyAccess Clinics to use CB2’s software within multi-clinic [...]
CryoSave has maintained without compromise the high-quality processing and storage services and has handed over its whole business.
19/09/2019
CryoSave has maintained without compromise the high-quality processing and storage services and has handed over its whole business. Switzerland – 19 September 2019 CryoSave has since its establishment in 2000, ensured [...]
Clearside Biomedical Featured at Multiple European Scientific Retinal Congresses
19/09/2019
ALPHARETTA, Ga., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people [...]
The Joint Corp. to Present at the 5th Annual B. Riley FBR Consumer & Media Conference
19/09/2019
SCOTTSDALE, Ariz., Sept. 19, 2019 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, announced it will present at the 5 th Annual B. Riley FBR [...]
Axogen, Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference
19/09/2019
ALACHUA, Fla., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, today announced [...]
Microbix Quality Products Enter U.S. Market
19/09/2019
Four IVD Controls to Support Performance of Human Papilloma Virus (HPV) Tests MISSISSAUGA, Ontario, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products [...]
Helsinn and Recordati Rare Diseases to announce satellite symposium on advances in Mycosis Fungoides-Cutaneous T cell Lymphoma
19/09/2019
Helsinn and Recordati Rare Diseases to announce satellite symposium on advances in Mycosis Fungoides-Cutaneous T cell Lymphoma (MF-CTCL) treatment at the 49th European Society for Dermatological Research Annual Meeting [...]

Pages